Clear Search
·
6 MIN READ

Nov. 3, 2017: National Advocacy Update

IPAB repeal legislation; opioids emergency declaration, biosimilars educational materials and more in the latest AMA national health care advocacy news.

Advocacy Update
·
5 MIN READ

June 29, 2017: State Advocacy Update

Nevada governor vetoes balance-billing legislation and AMA's opioid microsite in the latest state and local advocacy efforts.

Advocacy Update
Physician standing at a microphone making a comment.
·
3 MIN READ

More sunlight sought on spiking drug prices

Taking action on rising drug costs, the AMA House of Delegates calls for transparency, allowing CMS to negotiate prices and including prices in ads.

Public Health
·
3 MIN READ

AMA adopts policy aimed to bolster transparency of prescription costs

The AMA adopted several policies that aim to give patients more information about drugs prescribed to them and shed light on the rationale for price increases

Press Releases
·
4 MIN READ

Health care spending growth rate at its highest since 2007

Prescription drugs again outpaced all other categories of personal health care spending in 2015.

Research
·
4 MIN READ

Drug pricing needs transparency, physicians say

Physicians forcefully voice concerns about increasing prescription drug prices and call for transparency from pharmaceutical companies.

Public Health
·
5 MIN READ

Jan. 12, 2017: Advocacy spotlight on The top issues that will affect physicians in 2017

The top issues that will affect physicians in 2017: AMA's take on EHR interoperability, prescription drug pricing, the opioid epidemic and more.

Advocacy Update
Computer screens displaying top issues to watch in 2017.
·
4 MIN READ

The top issues that will affect physicians in 2017

Health care reform, the new Medicare payment system and regulatory relief are among the areas physicians should watch closely this year.

Access to Care
·
4 MIN READ

Physicians back steps toward value-based drug pricing

Recent increases in prescription drug spending prompt exploration of innovative ways to cut drug costs.

Public Health